| Grace Hospice 500 Kirts Blvd, Suite 250, Troy, MI, 48084 | |
| (248) 837-4390 |
News Archive
Cardiology informatics constitutes a complex and historically siloed environment. Yet, a new generation of solutions is going beyond just supporting individual service lines, and now more efficiently integrates and manages the diverse care area workflows of the cardiology enterprise.
A new tick-borne bacterium infecting humans with ehrlichiosis has been discovered in Wisconsin and Minnesota. It was identified as a new strain of bacteria through DNA testing conducted at Mayo Clinic.
The next generation of contraceptive implants offer an extremely effective way to expand family planning choices for women and reduce the incidence of maternal mortality worldwide, according to the latest issue of Population Reports, from the Johns Hopkins Bloomberg School of Public Health.
The Center for Science in the Public Interest has sued the German drug company Bayer for falsely claiming that the selenium in Men's One A Day multivitamins might reduce the risk of prostate cancer. The lawsuit is filed in the Superior Court of California in San Francisco.
Esperance Pharmaceuticals Inc. today reported positive results from a Phase II trial of lead candidate EP-100 in ovarian cancer patients resistant to paclitaxel. EP-100 is a targeted membrane-disrupting peptide designed to seek and destroy cancer cells that overexpress luteinizing hormone-releasing hormone (LHRH) receptors on their surfaces. LHRH receptors are over-expressed in a wide range of cancers.
› Verified 1 days ago
| Name | Grace Hospice |
|---|---|
| Location | 500 Kirts Blvd, Suite 250, Troy, Michigan |
| Hospice ID | 231611 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Other |
| Profit Type | FOR PROFIT |
| Accreditation Provider | Community Health Accreditation Partner (CHAP) |
| SSA county code | 620 |
News Archive
Cardiology informatics constitutes a complex and historically siloed environment. Yet, a new generation of solutions is going beyond just supporting individual service lines, and now more efficiently integrates and manages the diverse care area workflows of the cardiology enterprise.
A new tick-borne bacterium infecting humans with ehrlichiosis has been discovered in Wisconsin and Minnesota. It was identified as a new strain of bacteria through DNA testing conducted at Mayo Clinic.
The next generation of contraceptive implants offer an extremely effective way to expand family planning choices for women and reduce the incidence of maternal mortality worldwide, according to the latest issue of Population Reports, from the Johns Hopkins Bloomberg School of Public Health.
The Center for Science in the Public Interest has sued the German drug company Bayer for falsely claiming that the selenium in Men's One A Day multivitamins might reduce the risk of prostate cancer. The lawsuit is filed in the Superior Court of California in San Francisco.
Esperance Pharmaceuticals Inc. today reported positive results from a Phase II trial of lead candidate EP-100 in ovarian cancer patients resistant to paclitaxel. EP-100 is a targeted membrane-disrupting peptide designed to seek and destroy cancer cells that overexpress luteinizing hormone-releasing hormone (LHRH) receptors on their surfaces. LHRH receptors are over-expressed in a wide range of cancers.
› Verified 1 days ago
| NPI Number | 1952456857 |
| Organization Name | Heritage Home Hospice, Llc |
| Address | 500 Kirts Blvd Troy, Michigan, 48084 |
| Phone Number | (248)837-4390 |
News Archive
Cardiology informatics constitutes a complex and historically siloed environment. Yet, a new generation of solutions is going beyond just supporting individual service lines, and now more efficiently integrates and manages the diverse care area workflows of the cardiology enterprise.
A new tick-borne bacterium infecting humans with ehrlichiosis has been discovered in Wisconsin and Minnesota. It was identified as a new strain of bacteria through DNA testing conducted at Mayo Clinic.
The next generation of contraceptive implants offer an extremely effective way to expand family planning choices for women and reduce the incidence of maternal mortality worldwide, according to the latest issue of Population Reports, from the Johns Hopkins Bloomberg School of Public Health.
The Center for Science in the Public Interest has sued the German drug company Bayer for falsely claiming that the selenium in Men's One A Day multivitamins might reduce the risk of prostate cancer. The lawsuit is filed in the Superior Court of California in San Francisco.
Esperance Pharmaceuticals Inc. today reported positive results from a Phase II trial of lead candidate EP-100 in ovarian cancer patients resistant to paclitaxel. EP-100 is a targeted membrane-disrupting peptide designed to seek and destroy cancer cells that overexpress luteinizing hormone-releasing hormone (LHRH) receptors on their surfaces. LHRH receptors are over-expressed in a wide range of cancers.
› Verified 1 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.8 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 98.1 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 95.7 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 65.3 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 93.5 | 97.3 |
| Patients who got timely treatment for shortness of breath | 84.9 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 91.4 | 93.3 |
News Archive
Cardiology informatics constitutes a complex and historically siloed environment. Yet, a new generation of solutions is going beyond just supporting individual service lines, and now more efficiently integrates and manages the diverse care area workflows of the cardiology enterprise.
A new tick-borne bacterium infecting humans with ehrlichiosis has been discovered in Wisconsin and Minnesota. It was identified as a new strain of bacteria through DNA testing conducted at Mayo Clinic.
The next generation of contraceptive implants offer an extremely effective way to expand family planning choices for women and reduce the incidence of maternal mortality worldwide, according to the latest issue of Population Reports, from the Johns Hopkins Bloomberg School of Public Health.
The Center for Science in the Public Interest has sued the German drug company Bayer for falsely claiming that the selenium in Men's One A Day multivitamins might reduce the risk of prostate cancer. The lawsuit is filed in the Superior Court of California in San Francisco.
Esperance Pharmaceuticals Inc. today reported positive results from a Phase II trial of lead candidate EP-100 in ovarian cancer patients resistant to paclitaxel. EP-100 is a targeted membrane-disrupting peptide designed to seek and destroy cancer cells that overexpress luteinizing hormone-releasing hormone (LHRH) receptors on their surfaces. LHRH receptors are over-expressed in a wide range of cancers.
› Verified 1 days ago
| Home Health Aides | 24 |
| Counselors | 8 |
| Licensed Practical or Vocational Nurses | 4 |
| Medical Social Workers | 12 |
| Physicians | 11 |
| Registered Nurses | 36 |
| Other Personnel | 27 |
| Total Employees | 122 |
|---|
News Archive
Cardiology informatics constitutes a complex and historically siloed environment. Yet, a new generation of solutions is going beyond just supporting individual service lines, and now more efficiently integrates and manages the diverse care area workflows of the cardiology enterprise.
A new tick-borne bacterium infecting humans with ehrlichiosis has been discovered in Wisconsin and Minnesota. It was identified as a new strain of bacteria through DNA testing conducted at Mayo Clinic.
The next generation of contraceptive implants offer an extremely effective way to expand family planning choices for women and reduce the incidence of maternal mortality worldwide, according to the latest issue of Population Reports, from the Johns Hopkins Bloomberg School of Public Health.
The Center for Science in the Public Interest has sued the German drug company Bayer for falsely claiming that the selenium in Men's One A Day multivitamins might reduce the risk of prostate cancer. The lawsuit is filed in the Superior Court of California in San Francisco.
Esperance Pharmaceuticals Inc. today reported positive results from a Phase II trial of lead candidate EP-100 in ovarian cancer patients resistant to paclitaxel. EP-100 is a targeted membrane-disrupting peptide designed to seek and destroy cancer cells that overexpress luteinizing hormone-releasing hormone (LHRH) receptors on their surfaces. LHRH receptors are over-expressed in a wide range of cancers.
› Verified 1 days ago
| Others | 111 |
| Total Volunteers | 111 |
|---|
News Archive
Cardiology informatics constitutes a complex and historically siloed environment. Yet, a new generation of solutions is going beyond just supporting individual service lines, and now more efficiently integrates and manages the diverse care area workflows of the cardiology enterprise.
A new tick-borne bacterium infecting humans with ehrlichiosis has been discovered in Wisconsin and Minnesota. It was identified as a new strain of bacteria through DNA testing conducted at Mayo Clinic.
The next generation of contraceptive implants offer an extremely effective way to expand family planning choices for women and reduce the incidence of maternal mortality worldwide, according to the latest issue of Population Reports, from the Johns Hopkins Bloomberg School of Public Health.
The Center for Science in the Public Interest has sued the German drug company Bayer for falsely claiming that the selenium in Men's One A Day multivitamins might reduce the risk of prostate cancer. The lawsuit is filed in the Superior Court of California in San Francisco.
Esperance Pharmaceuticals Inc. today reported positive results from a Phase II trial of lead candidate EP-100 in ovarian cancer patients resistant to paclitaxel. EP-100 is a targeted membrane-disrupting peptide designed to seek and destroy cancer cells that overexpress luteinizing hormone-releasing hormone (LHRH) receptors on their surfaces. LHRH receptors are over-expressed in a wide range of cancers.
› Verified 1 days ago
| Mercy Hospice Location: 1111 W Long Lake Rd, Suite 102, Troy, Michigan, 48098 Phone: (248) 837-4390 |
| Grace Hospice Location: 500 Kirts Blvd, Suite 250, Troy, Michigan, 48084 Phone: (248) 837-4390 |
| Residential Hospice Location: 5440 Corporate Dr, Suite 400, Troy, Michigan, 48098 Phone: (248) 837-4390 |
| Premier Hospice Location: 33259 Dequindre Rd, Suite C, Troy, Michigan, 48083 Phone: (248) 837-4390 |